Literature DB >> 21515170

Difficulties in the translation of functionalized biomaterials into regenerative medicine clinical products.

Anthony Ratcliffe1.   

Abstract

There are many ways to influence cell activities, and biomaterials with functional groups attached is an attractive method that clearly has the ability to modulate cell behavior. The evidence is clear that biomaterials, with or without growth factors and cells, have resulted in numerous products for the regenerative medicine field. In contrast the functionalized biomaterial products remain in the development phase.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21515170      PMCID： PMC3082743          DOI： 10.1016/j.biomaterials.2011.02.028

Source DB:  PubMed          Journal:  Biomaterials        ISSN： 0142-9612            Impact factor:   12.479


  16 in total

1.  The story of Bioglass.

Authors:  Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

2.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.

Authors:  Shunmugam Govender; Cristina Csimma; Harry K Genant; Alexandre Valentin-Opran; Yehuda Amit; Ron Arbel; Hannu Aro; Dan Atar; Michael Bishay; Martin G Börner; Philippe Chiron; Peter Choong; John Cinats; Brett Courtenay; Robert Feibel; Bernard Geulette; Charles Gravel; Norbert Haas; M Raschke; Eric Hammacher; D van der Velde; Philippe Hardy; Michael Holt; Christof Josten; Rupert Ludwig Ketterl; Bennie Lindeque; Günter Lob; Henry Mathevon; Gerald McCoy; D Marsh; Russell Miller; Everard Munting; Stein Oevre; L Nordsletten; Amratlal Patel; Anthony Pohl; William Rennie; Peter Reynders; Pol Maria Rommens; Jean Rondia; Willem C Rossouw; P J Daneel; Stephen Ruff; Axel Rüter; Seppo Santavirta; Thomas A Schildhauer; C Gekle; Reinhard Schnettler; David Segal; Hanns Seiler; Robert B Snowdowne; Jouwert Stapert; Gilbert Taglang; Rene Verdonk; Lucas Vogels; Arnulf Weckbach; Andreas Wentzensen; Tadeusz Wisniewski
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

3.  Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.

Authors:  J Kenneth Burkus; Ensor E Transfeldt; Scott H Kitchel; Robert G Watkins; Richard A Balderston
Journal:  Spine (Phila Pa 1976)       Date:  2002-11-01       Impact factor: 3.468

4.  Culture of human umbilical vein endothelial cells on immobilized vascular endothelial growth factor.

Authors:  Yoshihiro Ito; Hirokazu Hasuda; Hiroshi Terai; Takashi Kitajima
Journal:  J Biomed Mater Res A       Date:  2005-09-15       Impact factor: 4.396

5.  Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte.

Authors:  Rohit J Kumar; Roy M Kimble; Robert Boots; Stuart P Pegg
Journal:  ANZ J Surg       Date:  2004-08       Impact factor: 1.872

6.  Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2).

Authors:  Alan S Herford; Philip J Boyne
Journal:  J Oral Maxillofac Surg       Date:  2008-04       Impact factor: 1.895

7.  Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.

Authors:  Vassilis Karageorgiou; Lorenz Meinel; Sandra Hofmann; Ajay Malhotra; Vladimir Volloch; David Kaplan
Journal:  J Biomed Mater Res A       Date:  2004-12-01       Impact factor: 4.396

Review 8.  A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon.

Authors:  Iain S Whitaker; Simon Prowse; Tom S Potokar
Journal:  Ann Plast Surg       Date:  2008-03       Impact factor: 1.539

9.  The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.

Authors:  William A Marston; Jason Hanft; Paul Norwood; Richard Pollak
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

10.  Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold.

Authors:  Atsuhiro Saito; Yoshihisa Suzuki; Makoto Kitamura; Shin-Ichi Ogata; Yusuke Yoshihara; Shingo Masuda; Chikara Ohtsuki; Masao Tanihara
Journal:  J Biomed Mater Res A       Date:  2006-06-15       Impact factor: 4.396
View more
  3 in total

Review 1.  Leveraging advances in biology to design biomaterials.

Authors:  Max Darnell; David J Mooney
Journal:  Nat Mater       Date:  2017-11-24       Impact factor: 43.841

Review 2.  Perspectives on the interface of drug delivery and tissue engineering.

Authors:  Adam K Ekenseair; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-09-20       Impact factor: 15.470

Review 3.  Biomimetic approaches with smart interfaces for bone regeneration.

Authors:  G S Sailaja; P Ramesh; Sajith Vellappally; Sukumaran Anil; H K Varma
Journal:  J Biomed Sci       Date:  2016-11-05       Impact factor: 8.410
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.